{"meta":{"id":"https:\/\/api.iclient.ifeng.com\/ipadtestdoc?aid=ucms_7x8oxeLMIYr","type":"doc","o":"1","documentId":"ucms_7x8oxeLMIYr"},"body":{"newStatus":"1","documentId":"ucms_7x8oxeLMIYr","staticId":"ucms_7x8oxeLMIYr","title":"康跃科技拟收购长江星医药控股权","shareTitle":"康跃科技拟收购长江星医药控股权","thumbnail_doc":"","thumbnail":"","source":"北京商报","author":"","editorcode":"weMedia","editTime":"2020-06-08 18:58:02","updateTime":"2020\/06\/08 18:58:02","wapurl":"http:\/\/\/\/finance.ifeng.com\/c\/7x8oxeLMIYr","introduction":"","wwwurl":"http:\/\/\/\/finance.ifeng.com\/c\/7x8oxeLMIYr","commentsUrl":"ucms_7x8oxeLMIYr","commentCount":0,"text":"
北京商报讯(记者 高萍)6月8日晚间,康跃科技(300391)披露公告称,公司拟以现金方式收购湖北长江星医药股份有限公司(以下简称“长江星医药”)不少于51%的股权。<\/p>
根据公告,长江星医药所属行业为卫生材料及医药用品制造,构筑了新型医药胶囊生产、医药物流网络、中成药新药、中药饮片及中药原料药生产为一体的医药产业链布局。<\/p>
康跃科技称,本次交易事项尚未签署任何协议,交易方案仍在论证协商,并需按照相关法律、法规及公司章程的规定履行必要的决策和审批程序。<\/p>
资料显示,康跃科技主要业务板块包括智能装备业务、内燃机零部件业务及光伏组件业务。公司此次拟购标的长江星医药曾在2018年2月首发辅导备案登记受理。<\/p>","img":[],"summary":"北京商报讯(记者高萍)6月8日晚间,康跃科技(300391)披露公告称,公司拟以现金方式收购湖北长江星医药股份有限公司(以下简称“长江星医药”)不少于51%的股","sharesummary":"北京商报讯(记者高萍)6月8日晚间,康跃科技(300391)披露公告称,公司拟以现金方式收购湖北长江星医药股份有限公司(以下简称“长江星医药”)不少于51%的股","commentType":"0","wemediaEAccountId":"4939","showclient":"0","shareurl":"https:\/\/ishare.ifeng.com\/c\/s\/v002BrzFrATe--yhTpvf-_yRo-_CqEKzxllZPI6yYonzT7RbNk__","praise":"0","like_num":"0"}}